
June 11, 2013
In this article about the positive results of a phase three trial run by Bayer Healthcare on the use of Nexavara tablets to treat liver cancer, Professor Masatoshi Kudo of Kinki University Faculty of Medicine comments on the possible wider use of the drug.
For more information, please click the link below.